Deposit your research

• Open Access
• About UCL Discovery
• UCL Discovery Plus
• REF and open access
• UCL Press
• UCL e-theses guidelines
• Statistics
• FAQs
• Notices and policies
• Contact us

Browse by UCL people

Export as ASCII CitationBibTeXEndNoteHTML CitationMultiline CSVObject IDsRDF+N-TriplesRDF+N3RDF+XMLReferReference Manager

Atom RSS 1.0 RSS 2.0

Group by: Type | Date

Jump to: Article | Proceedings paper | Working / discussion paper | Conference item

Number of items: 170.

Article

Abdel-Aty, H; O'Shea, L; Amos, C; Brown, LC; Grist, E; Attard, G; Clarke, N; ... James, N; + view all Abdel-Aty, H; O'Shea, L; Amos, C; Brown, LC; Grist, E; Attard, G; Clarke, N; Cross, W; Parker, C; Parmar, M; As, N Vas; James, N; - view fewer (2023) The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer. Clinical Oncology , 35 (10) e628-e635. 10.1016/j.clon.2023.07.009.

Abdel-Rahman, ME; Butler, J; Sydes, MR; Parmar, MK; Gordon, E; Harper, P; Williams, C; ... Coleman, MP; + view all Abdel-Rahman, ME; Butler, J; Sydes, MR; Parmar, MK; Gordon, E; Harper, P; Williams, C; Crook, A; Sandercock, J; Swart, AM; Rachet, B; Coleman, MP; - view fewer (2014) No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. Br J Cancer , 111 (3) pp. 589-597. 10.1038/bjc.2014.303.

ACTIV-3/TICO LY-CoV555 Study Group; (2021) A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. The New England Journal of Medicine , 384 pp. 905-914. 10.1056/NEJMoa2033130.

Adams, RA; Fisher, DJ; Graham, J; Seligmann, JF; Seymour, M; Kaplan, R; Yates, E; ... FOCUS4 Trial Investigators; + view all Adams, RA; Fisher, DJ; Graham, J; Seligmann, JF; Seymour, M; Kaplan, R; Yates, E; Parmar, M; Richman, SD; Quirke, P; Butler, R; Brown, E; Collinson, F; Falk, S; Wasan, H; Shiu, K-K; Middleton, G; Samuel, L; Wilson, RH; Brown, LC; Maughan, TS; FOCUS4 Trial Investigators; - view fewer (2021) Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 10.1200/JCO.21.01436. (In press).

Aggarwal, A; Court, LE; Hoskin, P; Jacques, I; Kroiss, M; Laskar, S; Lievens, Y; ... Langley, R; + view all Aggarwal, A; Court, LE; Hoskin, P; Jacques, I; Kroiss, M; Laskar, S; Lievens, Y; Mallick, I; Abdul Malik, R; Miles, E; Mohamad, I; Murphy, C; Nankivell, M; Parkes, J; Parmar, M; Roach, C; Simonds, H; Torode, J; Vanderstraeten, B; Langley, R; - view fewer (2023) ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocol. BMJ Open , 13 (12) , Article e077253. 10.1136/bmjopen-2023-077253.

Ahmed, HU; El-Shater Bosaily, A; Brown, LC; Gabe, R; Kaplan, R; Parmar, MK; Collaco-Moraes, Y; ... PROMIS study group; + view all Ahmed, HU; El-Shater Bosaily, A; Brown, LC; Gabe, R; Kaplan, R; Parmar, MK; Collaco-Moraes, Y; Ward, K; Hindley, RG; Freeman, A; Kirkham, AP; Oldroyd, R; Parker, C; Emberton, M; PROMIS study group; - view fewer (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet , 389 (10071) pp. 815-822. 10.1016/S0140-6736(16)32401-1.

Ali, A; Hoyle, AP; Parker, CC; Brawley, CD; Cook, A; Amos, C; Calvert, J; ... STAMPEDE investigators; + view all Ali, A; Hoyle, AP; Parker, CC; Brawley, CD; Cook, A; Amos, C; Calvert, J; Hassan, D; Mason, MD; Attard, G; Parmar, MKB; Sydes, M; James, ND; Clarke, NW; STAMPEDE investigators; - view fewer (2021) Bone metastatic burden as a predictor of survival benefit from prostate radiotherapy in newly-diagnosed metastatic prostate cancer. JAMA oncology , 7 (4) pp. 555-563. 10.1001/jamaoncol.2020.7857.

Ali, A; Plus 12 other authors, TPUWPO; Sydes, M; Clarke, NW; (2020) The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”. European Urology Oncology , 3 (4) pp. 412-419. 10.1016/j.euo.2020.05.003.

Attard, G; Brown, LC; Clarke, NW; Parmar, MKB; James, ND; (2021) Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE Trial. European Urology , 80 (4) pp. 522-523. 10.1016/j.eururo.2021.06.023.

Attard, G; Murphy, L; Clarke, NW; Sachdeva, A; Jones, C; Hoyle, A; Cross, W; ... McPhail, N; + view all Attard, G; Murphy, L; Clarke, NW; Sachdeva, A; Jones, C; Hoyle, A; Cross, W; Jones, RJ; Parker, CC; Gillessen, S; Cook, A; Brawley, C; Gilson, C; Rush, H; Abdel-Aty, H; Amos, CL; Murphy, C; Chowdhury, S; Malik, Z; Russell, JM; Parkar, N; Pugh, C; Diaz-Montana, C; Pezaro, C; Grant, W; Saxby, H; Pedley, I; O'Sullivan, JM; Birtle, A; Gale, J; Srihari, N; Thomas, C; Tanguay, J; Wagstaff, J; Das, P; Gray, E; Alzouebi, M; Parikh, O; Robinson, A; Montazeri, AH; Wylie, J; Zarkar, A; Cathomas, R; Brown, MD; Jain, Y; Dearnaley, DP; Mason, MD; Gilbert, D; Langley, RE; Millman, R; Matheson, D; Sydes, MR; Brown, LC; Parmar, MKB; James, ND; Jones, E; Hyde, K; Glen, H; Needleman, S; McGovern, U; Sheehan, D; Paisey, S; Shaffer, R; Beresford, M; Porfiri, E; Fackrell, D; Lee, L; Sreenivasan, T; Brock, S; Brown, S; Bahl, A; Smith-Howell, M; Woodward, C; Phan, MD; Mazhar, D; Narahari, K; Douglas, F; Kumar, A; Hamid, A; Ibrahim, A; Muthukumar, D; Simms, M; Worlding, J; Tran, A; Kagzi, M; Sivoglo, V; Masters, B; Keng-Koh, P; Manetta, C; McLaren, D; Gupta, N; Boussios, S; Taylor, H; Graham, J; Perna, C; Melcher, L; Sabharwal, A; Hofmann, U; Dealey, R; McPhail, N; - view fewer (2023) Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol. The Lancet Oncology , 24 (5) pp. 443-456. 10.1016/S1470-2045(23)00148-1.

Bailey, K; Ryan, A; Apostolidou, S; Fourkala, E; Burnell, M; Gentry-Maharaj, A; Kalsi, J; ... Menon, U; + view all Bailey, K; Ryan, A; Apostolidou, S; Fourkala, E; Burnell, M; Gentry-Maharaj, A; Kalsi, J; Parmar, M; Jacobs, I; Pikhart, H; Menon, U; - view fewer (2015) Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMC Public Health , 15 (253) , Article 1609. 10.1186/s12889-015-1609-5.

Barthel, FM-S; Parmar, MKB; Royston, P; (2009) How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design - a reanalysis of 4 trials. Trials , 10 , Article 21. 10.1186/1745-6215-10-21.

Bedia, Jacob S; Jacobs, Ian J; Ryan, Andy; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Singh, Naveena; Manchanda, Ranjit; ... Skates, Steven J; + view all Bedia, Jacob S; Jacobs, Ian J; Ryan, Andy; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Singh, Naveena; Manchanda, Ranjit; Kalsi, Jatinderpal K; Dawnay, Anne; Fallowfield, Lesley; Mcguire, Alistair J; Campbell, Stuart; Parmar, Mahesh KB; Menon, Usha; Skates, Steven J; - view fewer (2025) Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS. eBioMedicine , 112 , Article 105554. 10.1016/j.ebiom.2024.105554.

Bell, R; Brown, J; Parmar, M; Toi, M; Suter, T; Steger, GG; Pivot, X; ... Cameron, D; + view all Bell, R; Brown, J; Parmar, M; Toi, M; Suter, T; Steger, GG; Pivot, X; Mackey, J; Jackisch, C; Dent, R; Hall, P; Xu, N; Morales, L; Provencher, L; Hegg, R; Vanlemmens, L; Kirsch, A; Schneeweiss, A; Masuda, N; Overkamp, F; Cameron, D; - view fewer (2017) Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer. Annals of Oncology , 28 (4) pp. 754-760. 10.1093/annonc/mdw665.

Bird, SM; Strang, J; Ashby, D; Podmore, J; Robertson, JR; Welch, S; Meade, AM; Bird, SM; Strang, J; Ashby, D; Podmore, J; Robertson, JR; Welch, S; Meade, AM; Parmar, MKB; - view fewer (2017) External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial. Contemporary Clinical Trials Communications , 5 pp. 100-106. 10.1016/j.conctc.2017.01.006.

Blenkinsop, A; Parmar, MK; Choodari-Oskooei, B; (2019) Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework. Clinical Trials 10.1177/1740774518823551. (In press).

Blyuss, O; Burnell, M; Ryan, A; Gentry-Maharaj, A; Marino, I; Kalsi, J; Manchanda, R; ... Menon, U; + view all Blyuss, O; Burnell, M; Ryan, A; Gentry-Maharaj, A; Marino, I; Kalsi, J; Manchanda, R; Timms, J; Parmar, M; Skates, S; Jacobs, I; Zaikin, A; Menon, U; - view fewer (2018) Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population. Clinical Cancer Research 10.1158/1078-0432.CCR-18-0208. (In press).

Bouche, Gauthier; Gilbert, Duncan; Quartagno, Matteo; Dehbi, Hakim-Moulay; Merrick, Sophie; Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar; Stephens, Richard; ... Langley, Ruth E; + view all Bouche, Gauthier; Gilbert, Duncan; Quartagno, Matteo; Dehbi, Hakim-Moulay; Merrick, Sophie; Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar; Stephens, Richard; Parmar, Mahesh; Langley, Ruth E; - view fewer (2025) Determining the optimal use of approved drugs in oncology. The Lancet Oncology , 26 (5) e282-e294. 10.1016/S1470-2045(25)00037-3.

Bratton, DJ; Parmar, MK; Phillips, PP; Choodari-Oskooei, B; (2016) Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes. Trials , 17 , Article 309. 10.1186/s13063-016-1382-5.

Bratton, DJ; Phillips, PP; Parmar, MK; (2013) A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis. BMC Medical Research Methodology , 13 , Article 139. 10.1186/1471-2288-13-139.

Brown, LC; Ahmed, HU; Faria, R; El-Shater Bosaily, A; Gabe, R; Kaplan, RS; Parmar, M; ... Emberton, M; + view all Brown, LC; Ahmed, HU; Faria, R; El-Shater Bosaily, A; Gabe, R; Kaplan, RS; Parmar, M; Collaco-Moraes, Y; Ward, K; Hindley, RG; Freeman, A; Kirkham, A; Oldroyd, R; Parker, C; Bott, S; Burns-Cox, N; Dudderidge, T; Ghei, M; Henderson, A; Persad, R; Rosario, DJ; Shergill, I; Winkler, M; Soares, M; Spackman, E; Sculpher, M; Emberton, M; - view fewer (2018) Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Health Technology Assessment , 22 (39) xxxiii, 1-175. 10.3310/hta22390.

Burdett, S; Fisher, DJ; Vale, CL; Bono, AV; Clarke, NW; Cognetti, F; Collette, L; ... Tierney, JF; + view all Burdett, S; Fisher, DJ; Vale, CL; Bono, AV; Clarke, NW; Cognetti, F; Collette, L; Cote, RJ; Goebell, PJ; Groshen, S; Lehmann, J; Parmar, MKB; Rolevich, AI; Sonntag, RW; Sternberg, CN; Stockle, M; Studer, UE; Torti, FM; Zhegalik, AG; Tierney, JF; - view fewer (2022) Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials. European Urology , 81 (1) pp. 50-61. 10.1016/j.eururo.2021.09.028.

Burdett, S; Boeve, L; Ingleby, F; Fisher, D; Rydzewska, L; Vale, C; van Andel, G; ... Tierney, J; + view all Burdett, S; Boeve, L; Ingleby, F; Fisher, D; Rydzewska, L; Vale, C; van Andel, G; Clarke, N; Hulshof, M; James, N; Parker, C; Parmar, M; Sweeney, C; Sydes, M; Tombal, B; Verhagen, P; Tierney, J; - view fewer (2019) Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis. European Urology 10.1016/j.eururo.2019.02.003. (In press).

Burdett, S; Rydzewska, L; Tierney, J; Fisher, D; Parmar, MKB; Arriagada, R; Pignon, JP; ... PORT Meta-analysis Trialists Group, .; + view all Burdett, S; Rydzewska, L; Tierney, J; Fisher, D; Parmar, MKB; Arriagada, R; Pignon, JP; Le Pechoux, C; PORT Meta-analysis Trialists Group, .; - view fewer (2016) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database of Systematic Reviews , 10 , Article CD002142. 10.1002/14651858.CD002142.pub4.

Burnell, M; Gentry-Maharaj, A; Glazer, C; Karpinskyj, C; Ryan, A; Apostolidou, S; Kalsi, J; ... Menon, U; + view all Burnell, M; Gentry-Maharaj, A; Glazer, C; Karpinskyj, C; Ryan, A; Apostolidou, S; Kalsi, J; Parmar, M; Campbell, S; Jacobs, I; Menon, U; - view fewer (2020) Serial endometrial thickness and risk of non-endometrial hormone-dependent cancers in postmenopausal women in UKCTOCS. Ultrasound in Obstetrics & Gynecology , 56 (2) pp. 267-275. 10.1002/uog.21894.

Burnell, M; Gentry-Maharaj, A; Ryan, A; Apostolidou, S; Habib, M; Kalsi, J; Skates, S; ... Menon, U; + view all Burnell, M; Gentry-Maharaj, A; Ryan, A; Apostolidou, S; Habib, M; Kalsi, J; Skates, S; Parmar, M; Seif, MW; Amso, NN; Godfrey, K; Oram, D; Herod, J; Williamson, K; Jenkins, H; Mould, T; Woolas, R; Murdoch, J; Dobbs, S; Leeson, S; Cruickshank, D; Campbell, S; Fallowfield, L; Jacobs, I; Menon, U; - view fewer (2011) Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials. Trials , 12 , Article 61. 10.1186/1745-6215-12-61.

Burnell, M; Gentry-Maharaj, A; Skates, SJ; Ryan, A; Karpinskyj, C; Kalsi, J; Apostolidou, S; ... Menon, U; + view all Burnell, M; Gentry-Maharaj, A; Skates, SJ; Ryan, A; Karpinskyj, C; Kalsi, J; Apostolidou, S; Singh, N; Dawnay, A; Woolas, R; Fallowfield, L; Campbell, S; McGuire, A; Jacobs, IJ; Parmar, M; Menon, U; - view fewer (2021) UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis. Trials , 22 , Article 173. 10.1186/s13063-021-05125-8.

Choodari-Oskooei, B; Bratton, DJ; Gannon, MR; Meade, AM; Sydes, MR; Parmar, MKB; (2020) Adding new experimental arms to randomised clinical trials: Impact on error rates. Clinical Trials 10.1177/1740774520904346. (In press).

Choodari-Oskooei, B; Parmar, MK; Royston, P; Bowden, J; (2013) Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome. Trials , 14 , Article 23. 10.1186/1745-6215-14-23.

Choodari-Oskooei, B; Royston, P; Parmar, MKB; (2015) The extension of total gain (TG) statistic in survival models: Properties and applications. BMC Medical Research Methodology , 15 (1) , Article 50. 10.1186/s12874-015-0042-x.

Choudhury, T; Mozid, A; Hamshere, S; Yeo, C; Pellaton, C; Arnous, S; Saunders, N; ... Mathur, A; + view all Choudhury, T; Mozid, A; Hamshere, S; Yeo, C; Pellaton, C; Arnous, S; Saunders, N; Brookman, P; Jain, A; Locca, D; Archbold, A; Knight, C; Wragg, A; Davies, C; Mills, P; Parmar, M; Rothman, M; Choudry, F; Jones, DA; Agrawal, S; Martin, J; Mathur, A; - view fewer (2017) An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. European Journal of Heart Failure , 19 (1) pp. 138-147. 10.1002/ejhf.676.

Choudry, F; Hamshere, S; Saunders, N; Veerapen, J; Bavnbek, K; Knight, C; Pellerin, D; ... Mathur, A; + view all Choudry, F; Hamshere, S; Saunders, N; Veerapen, J; Bavnbek, K; Knight, C; Pellerin, D; Locca, D; Westwood, M; Rakhit, R; Crake, T; Kastrup, J; Parmar, M; Agrawal, S; Jones, D; Martin, J; Mathur, A; - view fewer (2016) A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†. European Heart Journal , 37 (3) pp. 256-263. 10.1093/eurheartj/ehv493.

Clamp, AR; James, EC; McNeish, IA; Dean, A; Kim, J-W; O'Donnell, DM; Hook, J; ... Ledermann, JA; + view all Clamp, AR; James, EC; McNeish, IA; Dean, A; Kim, J-W; O'Donnell, DM; Hook, J; Coyle, C; Blagden, S; Brenton, JD; Naik, R; Perren, T; Sundar, S; Cook, AD; Gopalakrishnan, GS; Gabra, H; Lord, R; Dark, G; Earl, HM; Hall, M; Banerjee, S; Glasspool, RM; Jones, R; Williams, S; Swart, AM; Stenning, S; Parmar, M; Kaplan, R; Ledermann, JA; - view fewer (2019) Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. The Lancet 10.1016/s0140-6736(19)32259-7.

Clarke, Caroline S; Hunter, Rachael M; Gabrio, Andrea; Brawley, Christopher D; Ingleby, Fiona C; Dearnaley, David P; Matheson, David; ... James, Nicholas D; + view all Clarke, Caroline S; Hunter, Rachael M; Gabrio, Andrea; Brawley, Christopher D; Ingleby, Fiona C; Dearnaley, David P; Matheson, David; Attard, Gerhardt; Rush, Hannah L; Jones, Rob J; Cross, William; Parker, Chris; Russell, J Martin; Millman, Robin; Gillessen, Silke; Malik, Zafar; Lester, Jason F; Wylie, James; Clarke, Noel W; Parmar, Mahesh KB; Sydes, Matthew R; James, Nicholas D; - view fewer (2022) Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. PLoS One , 17 (6) , Article e0269192. 10.1371/journal.pone.0269192.

Clarke, NW; Ali, A; Ingleby, FC; Hoyle, A; Amos, CL; Attard, G; Brawley, CD; ... STAMPEDE investigators; + view all Clarke, NW; Ali, A; Ingleby, FC; Hoyle, A; Amos, CL; Attard, G; Brawley, CD; Calvert, J; Chowdhury, S; Cook, A; Cross, W; Dearnaley, DP; Douis, H; Gilbert, D; Gillessen, S; Jones, RJ; Langley, RE; MacNair, A; Malik, Z; Mason, MD; Matheson, D; Millman, R; Parker, CC; Ritchie, AWS; Rush, H; Russell, JM; Brown, J; Beesley, S; Birtle, A; Capaldi, L; Gale, J; Gibbs, S; Lydon, A; Nikapota, A; Omlin, A; O'Sullivan, JM; Parikh, O; Protheroe, A; Rudman, S; Srihari, NN; Simms, M; Tanguay, JS; Tolan, S; Wagstaff, J; Wallace, J; Wylie, J; Zarkar, A; Sydes, MR; Parmar, MKB; James, ND; STAMPEDE investigators; - view fewer (2020) Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003. [Corrigendum]. Annals of Oncology , 31 (3) p. 442. 10.1016/j.annonc.2020.01.002.

Clarke, NW; Ali, A; Ingleby, FC; Hoyle, A; Amos, CL; Attard, G; Brawley, CD; ... James, ND; + view all Clarke, NW; Ali, A; Ingleby, FC; Hoyle, A; Amos, CL; Attard, G; Brawley, CD; Calvert, J; Chowdhury, S; Cook, A; Cross, W; Dearnaley, DP; Douis, H; Gilbert, D; Gillessen, S; Jones, RJ; Langley, RE; MacNair, A; Malik, Z; Mason, MD; Matheson, D; Millman, R; Parker, CC; Ritchie, AWS; Rush, H; Russell, JM; Brown, J; Beesley, S; Birtle, A; Capaldi, L; Gale, J; Gibbs, S; Lydon, A; Nikapota, A; Omlin, A; O'Sullivan, JM; Parikh, O; Protheroe, A; Rudman, S; Srihari, NN; Simms, M; Tanguay, JS; Tolan, S; Wagstaff, J; Wallace, J; Wylie, J; Zarkar, A; Sydes, MR; Parmar, MKB; James, ND; - view fewer (2019) Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. Annals of Oncology 10.1093/annonc/mdz396. (In press).

Collinson, F; Qian, W; Fossati, R; Lissoni, A; Williams, C; Parmar, M; Ledermann, J; ... on behalf of the ICON1 collaborators; + view all Collinson, F; Qian, W; Fossati, R; Lissoni, A; Williams, C; Parmar, M; Ledermann, J; Colombo, N; Swart, A; on behalf of the ICON1 collaborators; - view fewer (2014) Optimal treatment of early-stage ovarian cancer. Ann Oncol , 25 (6) pp. 1165-1171. 10.1093/annonc/mdu116.

Dearnaley, DP; Jovic, G; Syndikus, I; Khoo, V; Cowan, RA; Graham, JD; Aird, EG; ... Sydes, MR; + view all Dearnaley, DP; Jovic, G; Syndikus, I; Khoo, V; Cowan, RA; Graham, JD; Aird, EG; Bottomley, D; Huddart, RA; Jose, CC; Matthews, JH; Millar, JL; Murphy, C; Russell, JM; Scrase, CD; Parmar, MK; Sydes, MR; - view fewer (2014) Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. The Lancet Oncology , 15 (4) 464 - 473. 10.1016/S1470-2045(14)70040-3.

Dilley, J; Burnell, M; Gentry-Maharaj, A; Ryan, A; Neophytou, C; Apostolidou, S; Karpinskyj, C; ... Menon, U; + view all Dilley, J; Burnell, M; Gentry-Maharaj, A; Ryan, A; Neophytou, C; Apostolidou, S; Karpinskyj, C; Jatinderpal, K; Mould, T; Woolas, R; Singh, N; Widschwendter, M; Fallowfield, L; Campbell, S; Skates, SJ; McGuire, A; Parmar, M; Jacobs, I; Menon, U; - view fewer (2020) Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Gynecologic Oncology 10.1016/j.ygyno.2020.05.002. (In press).

Douin, David J; Siegel, Lianne; Grandits, Greg; Phillips, Andrew; Aggarwal, Neil R; Baker, Jason; Brown, Samuel M; ... ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study G; + view all Douin, David J; Siegel, Lianne; Grandits, Greg; Phillips, Andrew; Aggarwal, Neil R; Baker, Jason; Brown, Samuel M; Chang, Christina C; Goodman, Anna L; Grund, Birgit; Higgs, Elizabeth S; Hough, Catherine L; Murray, Daniel D; Paredes, Roger; Parmar, Mahesh; Pett, Sarah; Polizzotto, Mark N; Sandkovsky, Uriel; Self, Wesley H; Young, Barnaby E; Babiker, Abdel G; Davey, Victoria J; Kan, Virginia; Gelijns, Annetine C; Matthews, Gail; Thompson, B Taylor; Lane, H Clifford; Neaton, James D; Lundgren, Jens D; Ginde, Adit A; ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study G; - view fewer (2022) Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery. American Journal of Respiratory and Critical Care Medicine , 206 (6) pp. 730-739. 10.1164/rccm.202112-2836OC.

Downing, A; Morris, EJ; Corrigan, N; Sebag-Montefiore, D; Finan, PJ; Thomas, JD; Chapman, M; ... Selby, P; + view all Downing, A; Morris, EJ; Corrigan, N; Sebag-Montefiore, D; Finan, PJ; Thomas, JD; Chapman, M; Hamilton, R; Campbell, H; Cameron, D; Kaplan, R; Parmar, M; Stephens, R; Seymour, M; Gregory, W; Selby, P; - view fewer (2017) High hospital research participation and improved colorectal cancer survival outcomes: a population-based study. Gut , 66 (1) pp. 89-96. 10.1136/gutjnl-2015-311308.

Eisen, T; Frangou, E; Oza, B; Ritchie, AWS; Smith, B; Kaplan, R; Davis, ID; ... Meade, A; + view all Eisen, T; Frangou, E; Oza, B; Ritchie, AWS; Smith, B; Kaplan, R; Davis, ID; Stockler, MR; Albiges, L; Escudier, B; Larkin, J; Bex, A; Joniau, S; Hancock, B; Hermann, GG; Bellmunt, J; Hodgkinson, E; Stewart, GD; Barber, J; Brown, J; McMenemin, R; Nathan, P; Pickering, LM; Parmar, MKB; Meade, A; - view fewer (2020) Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial. Journal of Clinical Oncology , 38 (34) pp. 4064-4075. 10.1200/jco.20.01800.

Embleton-Thirsk, A; Deane, E; Townsend, S; Farrelly, L; Popoola, B; Parker, J; Rustin, G; ... Kaplan, R; + view all Embleton-Thirsk, A; Deane, E; Townsend, S; Farrelly, L; Popoola, B; Parker, J; Rustin, G; Sydes, M; Parmar, M; Ledermann, J; Kaplan, R; - view fewer (2019) Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application. Clinical Trials , 16 (5) pp. 502-511. 10.1177/1740774519862528.

Field, JK; Vulkan, D; Davies, MPA; Baldwin, DR; Brain, KE; Devaraj, A; Eisen, T; ... Duffy, SW; + view all Field, JK; Vulkan, D; Davies, MPA; Baldwin, DR; Brain, KE; Devaraj, A; Eisen, T; Gosney, J; Green, BA; Holemans, JA; Kavanagh, T; Kerr, KM; Ledson, M; Lifford, KJ; McRonald, FE; Nair, A; Page, RD; Parmar, MKB; Rassl, DM; Rintoul, RC; Screaton, NJ; Wald, NJ; Weller, D; Whynes, DK; Williamson, PR; Yadegarfar, G; Gabe, R; Duffy, SW; - view fewer (2021) Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. The Lancet Regional Health - Europe , 10 , Article 100179. 10.1016/j.lanepe.2021.100179.

Field, JK; Duffy, SW; Baldwin, DR; Brain, KE; Devaraj, A; Eisen, T; Green, BA; ... Hansell, DM; + view all Field, JK; Duffy, SW; Baldwin, DR; Brain, KE; Devaraj, A; Eisen, T; Green, BA; Holemans, JA; Kavanagh, T; Kerr, KM; Ledson, M; Lifford, KJ; McRonald, FE; Nair, A; Page, RD; Parmar, MK; Rintoul, RC; Screaton, N; Wald, NJ; Weller, D; Whynes, DK; Williamson, PR; Yadegarfar, G; Hansell, DM; - view fewer (2016) The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technology Assessment , 20 (40) 10.3310/hta20400.

Field, JK; Duffy, SW; Baldwin, DR; Whynes, DK; Devaraj, A; Brain, KE; Eisen, T; ... Hansell, DM; + view all Field, JK; Duffy, SW; Baldwin, DR; Whynes, DK; Devaraj, A; Brain, KE; Eisen, T; Gosney, J; Green, BA; Holemans, JA; Kavanagh, T; Kerr, KM; Ledson, M; Lifford, KJ; McRonald, FE; Nair, A; Page, RD; Parmar, MK; Rassl, DM; Rintoul, RC; Screaton, NJ; Wald, NJ; Weller, D; Williamson, PR; Yadegarfar, G; Hansell, DM; - view fewer (2016) UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax , 71 (2) pp. 161-170. 10.1136/thoraxjnl-2015-207140.

Fourkala, EO; Burnell, M; Cox, C; Ryan, A; Salter, LC; Gentry-Maharaj, A; Parmar, M; ... Menon, U; + view all Fourkala, EO; Burnell, M; Cox, C; Ryan, A; Salter, LC; Gentry-Maharaj, A; Parmar, M; Jacobs, I; Menon, U; - view fewer (2014) Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMJ Open , 4 (9) , Article e005400. 10.1136/bmjopen-2014-005400.

Gentry-Maharaj, A; Blyuss, O; Ryan, A; Burnell, M; Karpinskyj, C; Gunu, R; Kalsi, JK; ... Menon, U; + view all Gentry-Maharaj, A; Blyuss, O; Ryan, A; Burnell, M; Karpinskyj, C; Gunu, R; Kalsi, JK; Dawnay, A; Marino, IP; Manchanda, R; Lu, K; Yang, W-L; Timms, JF; Parmar, M; Skates, SJ; Bast, RC; Jacobs, IJ; Zaikin, A; Menon, U; - view fewer (2020) Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women. Cancers , 12 (7) , Article 1931. 10.3390/cancers12071931.

Gentry-Maharaj, A; Glazer, C; Burnell, M; Ryan, A; Berry, H; Kalsi, J; Woolas, R; ... Menon, U; + view all Gentry-Maharaj, A; Glazer, C; Burnell, M; Ryan, A; Berry, H; Kalsi, J; Woolas, R; Skates, SJ; Campbell, S; Parmar, M; Jacobs, I; Menon, U; - view fewer (2017) Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMJ Open , 7 (3) , Article e011822. 10.1136/bmjopen-2016-011822.

Ghimire, Bhagabati; Landy, Rebecca; Maroni, Roberta; Smith, Samuel G; Debiram-Beecham, Irene; Sasieni, Peter D; Fitzgerald, Rebecca C; ... Offman, Judith; + view all Ghimire, Bhagabati; Landy, Rebecca; Maroni, Roberta; Smith, Samuel G; Debiram-Beecham, Irene; Sasieni, Peter D; Fitzgerald, Rebecca C; Rubin, Greg; Walter, Fiona M; Waller, Jo; Offman, Judith; - view fewer (2023) Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial. BMC Gastroenterology , 23 (1) , Article 7. 10.1186/s12876-022-02630-1.

Ghorani, E; Quartagno, M; Blackhall, F; Gilbert, DC; O'Brien, M; Ottensmeier, C; Pizzo, E; ... on behalf of the REFINE-Lung, Investigators; + view all Ghorani, E; Quartagno, M; Blackhall, F; Gilbert, DC; O'Brien, M; Ottensmeier, C; Pizzo, E; Spicer, J; Williams, A; Badman, P; Parmar, MKB; Seckl, MJ; on behalf of the REFINE-Lung, Investigators; - view fewer (2023) REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment. The Lancet Oncology , 24 (5) e219-e227. 10.1016/S1470-2045(23)00095-5.

Gilbert, DC; Nankivell, M; Rush, H; Clarke, NW; Mangar, S; Al-Hasso, A; Rosen, S; ... Langley, RE; + view all Gilbert, DC; Nankivell, M; Rush, H; Clarke, NW; Mangar, S; Al-Hasso, A; Rosen, S; Kockelbergh, R; Sundaram, SK; Dixit, S; Laniado, M; McPhail, N; Shaheen, A; Brown, S; Gale, J; Deighan, J; Marshall, J; Duong, T; Macnair, A; Griffiths, A; Amos, CL; Sydes, MR; James, ND; Parmar, MKB; Langley, RE; - view fewer (2023) A Repurposing Programme Evaluating Repurposing Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design. Clinical Oncology 10.1016/j.clon.2023.10.054. (In press).

Gilbert, DC; Duong, T; Kynaston, HG; Alhasso, AA; Cafferty, FH; Rosen, SD; Kanaga-Sundaram, S; ... Abel, PD; + view all Gilbert, DC; Duong, T; Kynaston, HG; Alhasso, AA; Cafferty, FH; Rosen, SD; Kanaga-Sundaram, S; Dixit, S; Laniado, M; Madaan, S; Collins, G; Pope, A; Welland, A; Nankivell, M; Wassersug, R; Parmar, MK; Langley, RE; Abel, PD; - view fewer (2017) Quality of life outcomes from the PATCH trial evaluating LHRH agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. BJU International , 119 (5) pp. 667-675. 10.1111/bju.13687.

Gilbert, DC; Duong, T; Sydes, M; Bara, A; Clarke, N; Abel, P; James, N; ... STAMPEDE and PATCH Trial Management Groups, .; + view all Gilbert, DC; Duong, T; Sydes, M; Bara, A; Clarke, N; Abel, P; James, N; Langley, R; Parmar, M; STAMPEDE and PATCH Trial Management Groups, .; - view fewer (2018) Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform. BJU International , 121 (5) pp. 680-683. 10.1111/bju.14153.

Gilson, C; Chowdhury, S; Parmar, MKB; Sydes, MR; STAMPEDE Investigators; (2017) Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform. Clinical Oncology , 29 (12) pp. 778-786. 10.1016/j.clon.2017.10.004.

Gilson, C; Ingleby, F; Gilbert, DC; Parry, MA; Atako, NB; Ali, A; Hoyle, A; ... Chowdhury, S; + view all Gilson, C; Ingleby, F; Gilbert, DC; Parry, MA; Atako, NB; Ali, A; Hoyle, A; Clarke, NW; Gannon, M; Wanstall, C; Brawley, C; Mason, MD; Malik, Z; Simmons, A; Loehr, A; Parry-Jones, A; Eeles, R; Kote-Jarai, Z; James, ND; Amos, C; Parmar, MKB; Langley, RE; Sydes, MR; Attard, G; Chowdhury, S; - view fewer (2020) Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial. JCO Precision Oncology , 4 pp. 882-897. 10.1200/po.19.00388.

Glasbey, J; Beggs, A; Glimelius, B; Gray, R; Handley, K; Laurberg, S; Magill, L; ... Furniss, D; + view all Glasbey, J; Beggs, A; Glimelius, B; Gray, R; Handley, K; Laurberg, S; Magill, L; Murakami, K; Palmer, A; Quirke, P; Seligman, J; Seymour, M; Sinha, Y; West, N; Morton, D; Handley, K; Crosby, T; Olliff, J; Peto, R; Brown, G; Ferry, D; Gray, R; Handley, K; Ismail, T; Oliver, A; Scott, N; Swift, I; Warren, B; Northover, J; Parmar, M; Slevin, M; Gray, R; Handley, K; Wilcockson, A; Gray, Z; Lancaster, D; Brown, J; Adie, L; Kennedy, G; Eld, M; Holt, G; Yilmaz, M; Spendler, KG; Hansen, F; Laurberg, S; Rosenkilde, M; Ahlstrom, H; Abgamu, D; Day, N; Walsh, C; Bannister, J; Furniss, D; Morgan, S; Walkington, L; Yates, S; Branagan, G; Mustajab, A; O'Neil, H; Rees, C; Geh, I; Hendrickse, C; Langman, G; Pallan, A; Conn, A; Lowe, A; Ostrowski, J; Steward, M; Callaway, M; Falk, S; Thomas, M; Wong, N; Cast, J; Hartley, J; Roy, R; Tiam, R; Blunt, D; Cleator, S; Dawson, P; Goldin, R; Gujral, D; Lowdell, C; Ziprin, P; Clenton, S; Dewdney, A; Euinton, H; Furniss, D; - view fewer (2024) Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer: A Nested Case-control-matched Analysis of an International, Multicenter, Randomized Controlled Trial (FOxTROT). Annals of Surgery , 280 (2) pp. 283-293. 10.1097/SLA.0000000000006145.

González Martín, A; Oza, A; Embleton, AC; Pfisterer, J; Ledermann, J; Pujade-Lauraine, E; Kristensen, G; ... Perren, T; + view all González Martín, A; Oza, A; Embleton, AC; Pfisterer, J; Ledermann, J; Pujade-Lauraine, E; Kristensen, G; Bertrand, M; Beale, P; Cervantes, A; Kent, E; Kaplan, R; Parmar, M; Scotto, N; Perren, T; - view fewer (2019) Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer. Gynecologic Oncology , 152 (1) 10.1016/j.ygyno.2018.08.036.

Grieve, R; Abrams, K; Claxton, K; Goldacre, B; James, N; Nicholl, J; Parmar, M; ... Sculpher, M; + view all Grieve, R; Abrams, K; Claxton, K; Goldacre, B; James, N; Nicholl, J; Parmar, M; Parker, C; Sekhon, JS; Smeeth, L; Spiegelhalter, D; Sculpher, M; - view fewer (2016) Cancer Drugs Fund requires further reform. BMJ , 354 , Article i5090. 10.1136/bmj.i5090.

Hague, D; Townsend, S; Masters, L; Rauchenberger, M; Van Looy, N; Diaz Montana, C; Gannon, M; ... Sydes, M; + view all Hague, D; Townsend, S; Masters, L; Rauchenberger, M; Van Looy, N; Diaz Montana, C; Gannon, M; James, N; Maughan, T; Parmar, M; Brown, L; Sydes, M; - view fewer (2019) Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons. Trials , 20 , Article 294. 10.1186/s13063-019-3322-7.

Hamshere, S; Arnous, S; Choudhury, T; Choudry, F; Mozid, A; Yeo, C; Barrett, C; ... Mathur, A; + view all Hamshere, S; Arnous, S; Choudhury, T; Choudry, F; Mozid, A; Yeo, C; Barrett, C; Saunders, N; Gulati, A; Knight, C; Locca, D; Davies, C; Cowie, MR; Prasad, S; Parmar, M; Agrawal, S; Jones, D; Martin, J; McKenna, W; Mathur, A; - view fewer (2015) Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. European Heart Journal , 36 (44) pp. 3061-3069. 10.1093/eurheartj/ehv390.

Hoyle, AP; Ali, A; James, ND; Cook, A; Parker, CC; de Bono, JS; Attard, G; ... STAMPEDE Investigators; + view all Hoyle, AP; Ali, A; James, ND; Cook, A; Parker, CC; de Bono, JS; Attard, G; Chowdhury, S; Cross, WR; Dearnaley, DP; Brawley, CD; Gilson, C; Ingleby, F; Gillessen, S; Aebersold, DM; Jones, RJ; Matheson, D; Millman, R; Mason, MD; Ritchie, AWS; Russell, M; Douis, H; Parmar, MKB; Sydes, MR; Clarke, NW; STAMPEDE Investigators; - view fewer (2019) Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer. European Urology , 76 (6) pp. 719-728. 10.1016/j.eururo.2019.08.006.

Jacobs, IJ; Menon, U; Ryan, A; Gentry-Maharaj, A; Burnell, M; Kalsi, JK; Amso, NN; ... Skates, SJ; + view all Jacobs, IJ; Menon, U; Ryan, A; Gentry-Maharaj, A; Burnell, M; Kalsi, JK; Amso, NN; Apostolidou, S; Benjamin, E; Cruickshank, D; Crump, DN; Davies, SK; Dawnay, A; Dobbs, S; Fletcher, G; Ford, J; Godfrey, K; Gunu, R; Habib, M; Hallett, R; Herod, J; Jenkins, H; Karpinskyj, C; Leeson, S; Lewis, SJ; Liston, WR; Lopes, A; Mould, T; Murdoch, J; Oram, D; Rabideau, DJ; Reynolds, K; Scott, I; Seif, MW; Sharma, A; Singh, N; Taylor, J; Warburton, F; Widschwendter, M; Williamson, K; Woolas, R; Fallowfield, L; McGuire, AJ; Campbell, S; Parmar, M; Skates, SJ; - view fewer (2016) Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet , 387 (10022) pp. 945-956. 10.1016/S0140-6736(15)01224-6.

James, ND; Spears, MR; Clarke, NW; Dearnaley, DP; Mason, MD; Parker, CC; Ritchie, AW; ... STAMPEDE Investigators; + view all James, ND; Spears, MR; Clarke, NW; Dearnaley, DP; Mason, MD; Parker, CC; Ritchie, AW; Russell, JM; Schiavone, F; Attard, G; de Bono, JS; Birtle, A; Engeler, DS; Elliott, T; Matheson, D; O'Sullivan, J; Pudney, D; Srihari, N; Wallace, J; Barber, J; Syndikus, I; Parmar, MK; Sydes, MR; STAMPEDE Investigators; - view fewer (2016) Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial. JAMA Oncology , 2 (3) pp. 348-357. 10.1001/jamaoncol.2015.4350.

James, ND; de Bono, JS; Spears, MR; Clarke, NW; Mason, MD; Dearnaley, DP; Ritchie, AWS; ... STAMPEDE Investigators; + view all James, ND; de Bono, JS; Spears, MR; Clarke, NW; Mason, MD; Dearnaley, DP; Ritchie, AWS; Amos, CL; Gilson, C; Jones, RJ; Matheson, D; Millman, R; Attard, G; Chowdhury, S; Cross, WR; Gillessen, S; Parker, CC; Russell, JM; Berthold, DR; Brawley, C; Adab, F; Aung, S; Birtle, AJ; Bowen, J; Brock, S; Chakraborti, P; Ferguson, C; Gale, J; Gray, E; Hingorani, M; Hoskin, PJ; Lester, JF; Malik, ZI; McKinna, F; McPhail, N; Money-Kyrle, J; O'Sullivan, J; Parikh, O; Protheroe, A; Robinson, A; Srihari, NN; Thomas, C; Wagstaff, J; Wylie, J; Zarkar, A; Parmar, MKB; Sydes, MR; STAMPEDE Investigators; - view fewer (2017) Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. The New England Journal of Medicine , 377 pp. 338-351. 10.1056/NEJMoa1702900.

James, ND; Sydes, MR; Clarke, NW; Mason, MD; Dearnaley, DP; Spears, MR; Ritchie, AW; ... STAMPEDE investigators; + view all James, ND; Sydes, MR; Clarke, NW; Mason, MD; Dearnaley, DP; Spears, MR; Ritchie, AW; Parker, CC; Russell, JM; Attard, G; de Bono, J; Cross, W; Jones, RJ; Thalmann, G; Amos, C; Matheson, D; Millman, R; Alzouebi, M; Beesley, S; Birtle, AJ; Brock, S; Cathomas, R; Chakraborti, P; Chowdhury, S; Cook, A; Elliott, T; Gale, J; Gibbs, S; Graham, JD; Hetherington, J; Hughes, R; Laing, R; McKinna, F; McLaren, DB; O'Sullivan, JM; Parikh, O; Peedell, C; Protheroe, A; Robinson, AJ; Srihari, N; Srinivasan, R; Staffurth, J; Sundar, S; Tolan, S; Tsang, D; Wagstaff, J; Parmar, MK; STAMPEDE investigators; - view fewer (2016) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet , 387 (10024) pp. 1163-1177. 10.1016/S0140-6736(15)01037-5.

James, ND; Sydes, MR; Clarke, NW; Mason, MD; Parmar, MKB; (2016) STAMPEDE trial and patients with non-metastatic prostate cancer – Authors' reply. The Lancet , 388 (10041) pp. 235-236. 10.1016/S0140-6736(16)31041-8.

James, ND; Sydes, MR; Clarke, NW; Parmar, MKB; Ritchie, ASWR; (2016) Response to ‘High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice’, by Tanguay et al. Clinical Oncology , 28 (10) pp. 666-667. 10.1016/j.clon.2016.07.004.

Jinks, RC; Royston, P; Parmar, MK; (2015) Discrimination-based sample size calculations for multivariable prognostic models for time-to-event data. BMC Medical Research Methodology , 15 , Article 82. 10.1186/s12874-015-0078-y.

Joharatnam-Hogan, N; Cafferty, F; Hubner, R; Swinson, D; Sothi, S; Gupta, K; Falk, S; ... Add-Aspirin Trial Management Group; + view all Joharatnam-Hogan, N; Cafferty, F; Hubner, R; Swinson, D; Sothi, S; Gupta, K; Falk, S; Patel, K; Warner, N; Kunene, V; Rowley, S; Khabra, K; Underwood, T; Jankowski, J; Bridgewater, J; Crossley, A; Henson, V; Berkman, L; Gilbert, D; Kynaston, H; Ring, A; Cameron, D; Din, F; Graham, J; Iveson, T; Adams, R; Thomas, A; Wilson, R; Pramesh, CS; Langley, R; Add-Aspirin Trial Management Group; - view fewer (2019) Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. The Lancet Gastroenterology & Hepatology , 4 (11) pp. 854-862. 10.1016/S2468-1253(19)30289-4.

Kalsi, J; Gentry‐maharaj, A; Ryan, A; Singh, N; Burnell, M; Massingham, S; Apostolidou, S; ... Menon, U; + view all Kalsi, J; Gentry‐maharaj, A; Ryan, A; Singh, N; Burnell, M; Massingham, S; Apostolidou, S; Sharma, A; Williamson, K; Seif, M; Mould, T; Woolas, R; Dobbs, S; Leeson, S; Fallowfield, L; Skates, SJ; Parmar, M; Campbell, S; Jacobs, I; McGuire, A; Menon, U; - view fewer (2021) Performance characteristics of the ultrasound strategy during incidence screening in the UK collaborative trial of ovarian cancer screening (UKCTOCS). Cancers , 13 (4) , Article 858. 10.3390/cancers13040858.

Kalsi, JK; Ryan, A; Gentry-Maharaj, A; Margolin-Crump, D; Singh, N; Burnell, M; Benjamin, E; ... Menon, U; + view all Kalsi, JK; Ryan, A; Gentry-Maharaj, A; Margolin-Crump, D; Singh, N; Burnell, M; Benjamin, E; Apostolidou, S; Habib, M; Massingham, S; Karpinskyj, C; Woolas, R; Widschwendter, M; Fallowfield, L; Campbell, S; Skates, S; McGuire, A; Parmar, M; Jacobs, I; Menon, U; - view fewer (2021) Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar. Trials , 22 , Article 88. 10.1186/s13063-020-04968-x.

Karpinskyj, C; Burnell, M; Gonzalez-Izquierdo, A; Ryan, A; Kalsi, J; Jacobs, I; Parmar, M; ... Gentry-Maharaj, A; + view all Karpinskyj, C; Burnell, M; Gonzalez-Izquierdo, A; Ryan, A; Kalsi, J; Jacobs, I; Parmar, M; Menon, U; Gentry-Maharaj, A; - view fewer (2020) Socioeconomic Status and Ovarian Cancer Stage at Diagnosis: A Study Nested Within UKCTOCS. Diagnostics , 10 (2) , Article 89. 10.3390/diagnostics10020089.

Keshtkar-Jahromi, Maryam; Anstrom, Kevin J; Barkauskas, Christina; Brown, Samuel M; Daar, Eric S; Fischer, William; Gibbs, Kevin W; ... Adam, Stacey J; + view all Keshtkar-Jahromi, Maryam; Anstrom, Kevin J; Barkauskas, Christina; Brown, Samuel M; Daar, Eric S; Fischer, William; Gibbs, Kevin W; Higgs, Elizabeth S; Hughes, Michael D; Jagannathan, Prasanna; LaVange, Lisa; Lindsell, Christopher J; Nayak, Seema U; Paredes, Roger; Parmar, Mahesh; Peltan, Ithan D; Proschan, Michael; Shotwell, Matthew S; Vock, David M; Yokum, Tammy; Adam, Stacey J; - view fewer (2024) ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic. Journal of Clinical and Translational Science , 8 (1) , Article e151. 10.1017/cts.2024.1.

Kommoss, S; Winterhoff, B; Oberg, A; Konecny, GE; Wang, C; Riska, SM; Fan, JB; ... Pfisterer, J; + view all Kommoss, S; Winterhoff, B; Oberg, A; Konecny, GE; Wang, C; Riska, SM; Fan, JB; Maurer, MJ; April, C; Shridhar, V; Kommoss, F; du Bois, A; Hilpert, F; Mahner, S; Baumann, K; Schroeder, W; Burges, A; Canzler, U; Chien, J; Embleton, AC; Parmar, M; Kaplan, R; Perren, T; Hartmann, LC; Goode, EL; Dowdy, SC; Pfisterer, J; - view fewer (2017) Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes. Clinical Cancer Research , 23 (14) pp. 3794-3801. 10.1158/1078-0432.CCR-16-2196.

Lacas, B; Bourhis, J; Overgaard, J; Zhang, Q; Grégoire, V; Nankivell, M; Zackrisson, B; ... MARCH Collaborative Group; + view all Lacas, B; Bourhis, J; Overgaard, J; Zhang, Q; Grégoire, V; Nankivell, M; Zackrisson, B; Szutkowski, Z; Suwiński, R; Poulsen, M; O'Sullivan, B; Corvò, R; Laskar, SG; Fallai, C; Yamazaki, H; Dobrowsky, W; Cho, KH; Garden, AS; Langendijk, JA; Viegas, CMP; Hay, J; Lotayef, M; Parmar, MKB; Aupérin, A; van Herpen, C; Maingon, P; Trotti, AM; Grau, C; Pignon, J-P; Blanchard, P; MARCH Collaborative Group; - view fewer (2017) Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol , 18 (9) pp. 1221-1237. 10.1016/S1470-2045(17)30458-8.

Langley, RE; Kynaston, HG; Alhasso, AA; Duong, T; Paez, EM; Jovic, G; Scrase, CD; ... Abel, PD; + view all Langley, RE; Kynaston, HG; Alhasso, AA; Duong, T; Paez, EM; Jovic, G; Scrase, CD; Robertson, A; Cafferty, F; Welland, A; Carpenter, R; Honeyfield, L; Abel, RL; Stone, M; Parmar, MK; Abel, PD; - view fewer (2016) A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol. European Urology , 69 (6) pp. 1016-1025. 10.1016/j.eururo.2015.11.030.

Langley, RE; Gilbert, DC; Duong, T; Clarke, NW; Nankivell, M; Rosen, SD; Mangar, S; ... Parmar, M; + view all Langley, RE; Gilbert, DC; Duong, T; Clarke, NW; Nankivell, M; Rosen, SD; Mangar, S; Macnair, A; Sundaram, SK; Laniado, ME; Dixit, S; Madaan, S; Manetta, C; Pope, A; Scrase, CD; Mckay, S; Muazzam, IA; Collins, GN; Worlding, J; Williams, ST; Paez, E; Robinson, A; McFarlane, J; Deighan, JV; Marshall, J; Forcat, S; Weiss, M; Kockelbergh, R; Alhasso, A; Kynaston, H; Parmar, M; - view fewer (2021) Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet , 397 (10274) pp. 581-591. 10.1016/s0140-6736(21)00100-8.

Ledermann, JA; Embleton, AC; Raja, F; Perren, TJ; Jayson, GC; Rustin, GJS; Kaye, SB; ... Collaborators, I; + view all Ledermann, JA; Embleton, AC; Raja, F; Perren, TJ; Jayson, GC; Rustin, GJS; Kaye, SB; Hirte, H; Eisenhauer, E; Vaughan, M; Friedlander, M; Gonzalez-Martin, A; Stark, D; Clark, E; Farrelly, L; Swart, AM; Cook, A; Kaplan, RS; Parmar, MKB; Collaborators, I; - view fewer (2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet , 387 (10023) pp. 1066-1074. 10.1016/S0140-6736(15)01167-8.

Ledermann, JA; Embleton-Thirsk, AC; Perren, TJ; Jayson, GC; Rustin, GJS; Kaye, SB; Hirte, H; ... ICON6 collaborators, .; + view all Ledermann, JA; Embleton-Thirsk, AC; Perren, TJ; Jayson, GC; Rustin, GJS; Kaye, SB; Hirte, H; Oza, A; Vaughan, M; Friedlander, M; González-Martín, A; Deane, E; Popoola, B; Farrelly, L; Swart, AM; Kaplan, RS; Parmar, MKB; ICON6 collaborators, .; - view fewer (2021) Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial. ESMO Open , 6 (2) , Article 100043. 10.1016/j.esmoop.2020.100043.

Li, Vivien; Leurent, Baptiste; Barkhof, Frederik; Braisher, Marie; Cafferty, Fay; Ciccarelli, Olga; Eshaghi, Arman; ... Chataway, Jeremy; + view all Li, Vivien; Leurent, Baptiste; Barkhof, Frederik; Braisher, Marie; Cafferty, Fay; Ciccarelli, Olga; Eshaghi, Arman; Gray, Emma; Nicholas, Jennifer M; Parmar, Mahesh; Peryer, Guy; Robertson, Jenny; Stallard, Nigel; Wason, James; Chataway, Jeremy; - view fewer (2022) Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis. Neurology 10.1212/WNL.0000000000200604. (In press).

Limkin, Elaine; Blanchard, Pierre; Lacas, Benjamin; Bourhis, Jean; Parmar, Mahesh; Licitra, Lisa; Le, Quynh-Thu; ... MACH-NC* and MARCH** collaborative groups; + view all Limkin, Elaine; Blanchard, Pierre; Lacas, Benjamin; Bourhis, Jean; Parmar, Mahesh; Licitra, Lisa; Le, Quynh-Thu; Yom, Sue S; Fortpied, Catherine; Langendijk, Johannes; Vermorken, Jan B; Bernier, Jacques; Overgaard, Jens; Harris, Jonathan; Pignon, Jean-Pierre; Auperin, Anne; MACH-NC* and MARCH** collaborative groups; - view fewer (2024) Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses. Radiotherapy & Oncology , 190 , Article 110011. 10.1016/j.radonc.2023.110011.

Lynn, M; Goulden, B; Parmar, M; Knopp, P; Yeung, M; Giles, I; Davies, C; ... Davis, D; + view all Lynn, M; Goulden, B; Parmar, M; Knopp, P; Yeung, M; Giles, I; Davies, C; Espinosa, A; Davis, D; - view fewer (2020) Play attention! Therapeutic aspects to play in delirium prevention and management [version 1; peer review: 1 approved]. Wellcome Open Research , 5 , Article 277. 10.12688/wellcomeopenres.16199.1.

Macnair, A; Love, SB; Murray, ML; Gilbert, DC; Parmar, MKB; Denwood, T; Carpenter, J; ... Cafferty, FH; + view all Macnair, A; Love, SB; Murray, ML; Gilbert, DC; Parmar, MKB; Denwood, T; Carpenter, J; Sydes, MR; Langley, RE; Cafferty, FH; - view fewer (2021) Accessing routinely collected health data to improve clinical trials: recent experience of access. Trials , 22 , Article 340. 10.1186/s13063-021-05295-5.

Mason, MD; Clarke, NW; James, ND; Dearnaley, DP; Spears, MR; Ritchie, AWS; Attard, G; ... STAMPEDE Investigators, .; + view all Mason, MD; Clarke, NW; James, ND; Dearnaley, DP; Spears, MR; Ritchie, AWS; Attard, G; Cross, W; Jones, RJ; Parker, CC; Russell, JM; Thalmann, GN; Schiavone, F; Cassoly, E; Matheson, D; Millman, R; Rentsch, CA; Barber, J; Gilson, C; Ibrahim, A; Logue, J; Lydon, A; Nikapota, AD; O'Sullivan, JM; Porfiri, E; Protheroe, A; Srihari, NN; Tsang, D; Wagstaff, J; Wallace, J; Walmsley, C; Parmar, MKB; Sydes, MR; STAMPEDE Investigators, .; - view fewer (2017) Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial. Journal of Clincal Oncology , 35 (14) pp. 1530-1541. 10.1200/JCO.2016.69.0677.

Mason, MD; Parulekar, WR; Sydes, MR; Brundage, M; Kirkbride, P; Gospodarowicz, M; Cowan, R; ... Warde, P; + view all Mason, MD; Parulekar, WR; Sydes, MR; Brundage, M; Kirkbride, P; Gospodarowicz, M; Cowan, R; Kostashuk, EC; Anderson, J; Swanson, G; Parmar, MK; Hayter, C; Jovic, G; Hiltz, A; Hetherington, J; Sathya, J; Barber, JB; McKenzie, M; El-Sharkawi, S; Souhami, L; Hardman, PD; Chen, BE; Warde, P; - view fewer (2015) Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer. Journal of Clinical Oncology , 33 (19) pp. 2143-2150. 10.1200/JCO.2014.57.7510.

Mauguen, A; Pignon, JP; Burdett, S; Domerg, C; Fisher, D; Paulus, R; Mandrekar, SJ; ... Surrogate Lung Project Collaborative Group; + view all Mauguen, A; Pignon, JP; Burdett, S; Domerg, C; Fisher, D; Paulus, R; Mandrekar, SJ; Belani, CP; Shepherd, FA; Eisen, T; Pang, H; Collette, L; Sause, WT; Dahlberg, SE; Crawford, J; O'Brien, M; Schild, SE; Parmar, M; Tierney, JF; Le Pechoux, C; Michiels, S; Surrogate Lung Project Collaborative Group; - view fewer (2013) Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. Lancet Oncology , 14 (7) 619 - 626. 10.1016/S1470-2045(13)70158-X.

Meade, A; Oza, B; Frangou, E; Smith, B; Bryant, H; Kaplan, R; Choodari-Oskooei, B; ... Parmar, MKB; + view all Meade, A; Oza, B; Frangou, E; Smith, B; Bryant, H; Kaplan, R; Choodari-Oskooei, B; Powles, T; Stewart, GD; Albiges, L; Bex, A; Choueiri, TK; Davis, ID; Eisen, T; Fielding, A; Harrison, DJ; McWhirter, A; Mulhere, S; Nathan, P; Rini, B; Ritchie, A; Scovell, S; Shakeshaft, C; Stockler, MR; Thorogood, N; Larkin, J; Parmar, MKB; - view fewer (2021) RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting. Contemporary Clinical Trials , 108 , Article 106481. 10.1016/j.cct.2021.106481.

Meade, AM; Bird, SM; Strang, J; Pepple, T; Nichols, LL; Mascarenhas, M; Choo, L; Meade, AM; Bird, SM; Strang, J; Pepple, T; Nichols, LL; Mascarenhas, M; Choo, L; Parmar, MKB; - view fewer (2017) Methods for delivering the UK's multi-centre prison-based naloxone-on-release pilot randomised trial (N-ALIVE): Europe's largest prison-based randomised controlled trial. Drug and Alcohol Review 10.1111/dar.12592. (In press).

Mehta, AR; Carpenter, JR; Nicholas, JM; Chataway, J; Virgo, B; Parmar, MKB; Chandran, S; Mehta, AR; Carpenter, JR; Nicholas, JM; Chataway, J; Virgo, B; Parmar, MKB; Chandran, S; Pal, S; - view fewer (2023) The role of placebo control in clinical trials for neurodegenerative diseases. [Letter]. Nature Medicine 10.1038/d41591-023-00080-0.

Mehta, Arpan R; Pal, Suvankar; Chataway, Jeremy; Carpenter, James R; Parmar, Mahesh KB; Chandran, Siddharthan; (2022) Smarter adaptive platform clinical trials in neurology: a showcase for UK innovation. Brain , 145 (8) e64-e65. 10.1093/brain/awac169.

Menon, Usha; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Apostolidou, Sophia; Ryan, Andy; Kalsi, Jatinderpal K; Singh, Naveena; ... UKCTOCS team; + view all Menon, Usha; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Apostolidou, Sophia; Ryan, Andy; Kalsi, Jatinderpal K; Singh, Naveena; Fallowfield, Lesley; McGuire, Alistair J; Campbell, Stuart; Skates, Steven J; Dawnay, Anne; Parmar, Mahesh; Jacobs, Ian J; UKCTOCS team; - view fewer (2023) Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials. Health Technology Assessment pp. 1-38. 10.3310/CLDC7214.

Menon, Usha; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Ryan, Andy; Kalsi, Jatinderpal K; Singh, Naveena; Dawnay, Anne; ... Jacobs, Ian J; + view all Menon, Usha; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Ryan, Andy; Kalsi, Jatinderpal K; Singh, Naveena; Dawnay, Anne; Fallowfield, Lesley; McGuire, Alistair J; Campbell, Stuart; Skates, Steven J; Parmar, Mahesh; Jacobs, Ian J; - view fewer (2023) Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. Health Technology Assessment , 11 pp. 1-81. 10.3310/BHBR5832.

Menon, U; Burnell, M; Sharma, A; Gentry-Maharaj, A; Fraser, L; Ryan, A; Parmar, M; ... UKCTOCS Group; + view all Menon, U; Burnell, M; Sharma, A; Gentry-Maharaj, A; Fraser, L; Ryan, A; Parmar, M; Hunter, M; Jacobs, I; UKCTOCS Group; - view fewer (2007) Decline in use of hormone therapy among postmenopausal women in the United Kingdom. Menopause , 14 (3) 462 - 467. 10.1097/01.gme.0000243569.70946.9d.

Menon, U; Gentry-Maharaj, A; Burnell, M; Singh, N; Ryan, A; Karpinskyj, C; Carlino, G; ... Parmar, M; + view all Menon, U; Gentry-Maharaj, A; Burnell, M; Singh, N; Ryan, A; Karpinskyj, C; Carlino, G; Taylor, J; Massingham, SK; Raikou, M; Kalsi, JK; Woolas, R; Manchanda, R; Arora, R; Casey, L; Dawnay, A; Dobbs, S; Leeson, S; Mould, T; Seif, MW; Sharma, A; Williamson, K; Liu, Y; Fallowfield, L; McGuire, AJ; Campbell, S; Skates, SJ; Jacobs, IJ; Parmar, M; - view fewer (2021) Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. The Lancet 10.1016/s0140-6736(21)00731-5. (In press).

Menon, U; Kalsi, JK; Gentry-Maharaj, A; Ryan, A; Burnell, M; Parmar, M; Fallowfield, L; ... Jacobs, I; + view all Menon, U; Kalsi, JK; Gentry-Maharaj, A; Ryan, A; Burnell, M; Parmar, M; Fallowfield, L; Campbell, S; McGuire, A; Skates, S; Jacobs, I; - view fewer (2016) Reply to P.F. Pinsky, C.P. Crum, and M.W. McIntosh et al. [Rapid communication]. Journal of Clinical Oncology , 34 (2) pp. 201-202. 10.1200/JCO.2015.64.1365.

Menon, U; McGuire, AJ; Raikou, M; Ryan, A; Davies, SK; Burnell, M; Gentry-Maharaj, A; ... Jacobs, IJ; + view all Menon, U; McGuire, AJ; Raikou, M; Ryan, A; Davies, SK; Burnell, M; Gentry-Maharaj, A; Kalsi, JK; Singh, N; Amso, NN; Cruickshank, D; Dobbs, S; Godfrey, K; Herod, J; Leeson, S; Mould, T; Murdoch, J; Oram, D; Scott, I; Seif, MW; Williamson, K; Woolas, R; Fallowfield, L; Campbell, S; Skates, SJ; Parmar, M; Jacobs, IJ; - view fewer (2017) The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). British Journal of Cancer , 117 (5) pp. 619-627. 10.1038/bjc.2017.222.

Menon, U; Ryan, A; Kalsi, J; Gentry-Maharaj, A; Dawnay, A; Habib, M; Apostolidou, S; ... Jacobs, I; + view all Menon, U; Ryan, A; Kalsi, J; Gentry-Maharaj, A; Dawnay, A; Habib, M; Apostolidou, S; Singh, N; Benjamin, E; Burnell, M; Davies, S; Sharma, A; Gunu, R; Godfrey, K; Lopes, A; Oram, D; Herod, J; Williamson, K; Seif, MW; Jenkins, H; Mould, T; Woolas, R; Murdoch, JB; Dobbs, S; Amso, NN; Leeson, S; Cruickshank, D; Scott, I; Fallowfield, L; Widschwendter, M; Reynolds, K; McGuire, A; Campbell, S; Parmar, M; Skates, SJ; Jacobs, I; - view fewer (2015) Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Journal of Clinical Oncology , 33 (18) pp. 2062-2071. 10.1200/JCO.2014.59.4945.

Morrell, L; Hordern, J; Brown, L; Sydes, MR; Amos, CL; Kaplan, RS; Parmar, MKB; Morrell, L; Hordern, J; Brown, L; Sydes, MR; Amos, CL; Kaplan, RS; Parmar, MKB; Maughan, TS; - view fewer (2019) Mind the gap? The platform trial as a working environment. Trials , 20 (1) , Article 297. 10.1186/s13063-019-3377-5.

Mulvenna, P; Nankivell, M; Barton, R; Faivre-Finn, C; Wilson, P; McColl, E; Moore, B; ... Langley, RE; + view all Mulvenna, P; Nankivell, M; Barton, R; Faivre-Finn, C; Wilson, P; McColl, E; Moore, B; Brisbane, I; Ardron, D; Holt, T; Morgan, S; Lee, C; Waite, K; Bayman, N; Pugh, C; Sydes, B; Stephens, R; Parmar, MK; Langley, RE; - view fewer (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet , 388 (10055) pp. 2004-2014. 10.1016/S0140-6736(16)30825-X.

Murray, DD; Babiker, AG; Baker, JV; Barkauskas, CE; Brown, SM; Chang, CC; Davey, VJ; ... Lundgren, JD; + view all Murray, DD; Babiker, AG; Baker, JV; Barkauskas, CE; Brown, SM; Chang, CC; Davey, VJ; Gelijns, AC; Ginde, AA; Grund, B; Higgs, E; Hudson, F; Kan, VL; Lane, HC; Murray, TA; Paredes, R; Parmar, MK; Pett, S; Phillips, AN; Polizzotto, MN; Reilly, C; Sandkovsky, U; Sharma, S; Teitelbaum, M; Thompson, BT; Young, BE; Neaton, JD; Lundgren, JD; - view fewer (2021) Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Clinical Trials 10.1177/17407745211049829. (In press).

Nankivell, M; Langley, RE; Barton, R; Faivre-Finn, C; Wilson, P; McColl, E; Moore, B; ... Mulvenna, P; + view all Nankivell, M; Langley, RE; Barton, R; Faivre-Finn, C; Wilson, P; McColl, E; Moore, B; Brisbane, I; Ardron, D; Sydes, B; Stephens, R; Parmar, M; Mulvenna, P; - view fewer (2017) How do the QUARTZ trial results inform future research for patients with brain metastases from non-small cell lung cancer? [Letter]. Translational Cancer Research , 6 (Supp. 02) S446-S447. 10.21037/tcr.2017.03.08.

Nankivell, M; Stephens, R; Pugh, C; Mulvenna, P; Barton, R; Langley, R; Parmar, M; (2011) Releasing interim results from a randomised clinical trial: an example from the QUARTZ trial. Trials , 12 Sup , Article A125. 10.1186/1745-6215-12-S1-A125.

Navani, N; Fisher, D; Tierney, JF; Stephens, RJ; Burdett, S; NSCLC Meta-analysis Collaborative Group, .; (2019) The accuracy of clinical staging of stage I-IIIa non-small cell lung cancer: An analysis based on individual participant data. Chest , 155 (3) pp. 502-509. 10.1016/j.chest.2018.10.020.

Navani, N; Nankivell, M; Lawrence, DR; Lock, S; Makker, H; Baldwin, DR; Stephens, RJ; ... Lung-BOOST trial investigators, .; + view all Navani, N; Nankivell, M; Lawrence, DR; Lock, S; Makker, H; Baldwin, DR; Stephens, RJ; Parmar, MK; Spiro, SG; Morris, S; Janes, SM; Lung-BOOST trial investigators, .; - view fewer (2015) Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. The Lancet Respiratory Medicine , 3 (4) 282 - 289. 10.1016/S2213-2600(15)00029-6.

Noor, Nurulamin M; Love, Sharon B; Isaacs, Talia; Kaplan, Richard; Parmar, Mahesh KB; Sydes, Matthew R; (2022) Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials. BMJ Open , 12 (3) , Article e055615. 10.1136/bmjopen-2021-055615.

Noor, NM; Pett, SL; Esmail, H; Crook, AM; Vale, CL; Sydes, MR; Parmar, MKB; (2020) Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings [version 2; peer review: 2 approved]. F1000Research , 9 , Article 1109. 10.12688/f1000research.26253.2.

Oza, B; Frangou, E; Smith, B; Bryant, H; Kaplan, R; Choodari-Oskooei, B; Powles, T; ... Meade, A; + view all Oza, B; Frangou, E; Smith, B; Bryant, H; Kaplan, R; Choodari-Oskooei, B; Powles, T; Stewart, GD; Albiges, L; Bex, A; Choueiri, TK; Davis, ID; Eisen, T; Fielding, A; Harrison, D; McWhirter, A; Mulhere, S; Nathan, P; Rini, B; Ritchie, A; Scovell, S; Shakeshaft, C; Stockler, MR; Thorogood, N; Parmar, MKB; Larkin, J; Meade, A; - view fewer (2021) RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse. Contemporary Clinical Trials , 108 , Article 106482. 10.1016/j.cct.2021.106482.

Oza, Bhavna; Eisen, Tim; Frangou, Eleni; Stewart, Grant D; Bex, Axel; Ritchie, Alastair WS; Kaplan, Rick; ... Meade, Angela; + view all Oza, Bhavna; Eisen, Tim; Frangou, Eleni; Stewart, Grant D; Bex, Axel; Ritchie, Alastair WS; Kaplan, Rick; Smith, Benjamin; Davis, Ian D; Stockler, Martin R; Albiges, Laurence; Escudier, Bernard; Larkin, James; Joniau, Steven; Hancock, Barry; Hermann, Gregers G; Bellmunt, Joaquim; Parmar, Mahesh KB; Royston, Patrick; Meade, Angela; - view fewer (2022) External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer. Journal of Clinical Oncology 10.1200/JCO.21.01090. (In press).

Oza, AM; Cook, AD; Pfisterer, J; Embleton, A; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; ... ICON7, trial investigators; + view all Oza, AM; Cook, AD; Pfisterer, J; Embleton, A; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; Carey, MS; Beale, P; Cervantes, A; Park-Simon, TW; Rustin, G; Joly, F; Mirza, MR; Plante, M; Quinn, M; Poveda, A; Jayson, GC; Stark, D; Swart, AM; Farrelly, L; Kaplan, R; Parmar, MK; Perren, TJ; ICON7, trial investigators; - view fewer (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncology , 16 (8) pp. 928-936. 10.1016/S1470-2045(15)00086-8.

Papadatos-Pastos, D; Yuan, W; Pal, A; Crespo, M; Ferreira, A; Gurel, B; Prout, T; ... Minchom, A; + view all Papadatos-Pastos, D; Yuan, W; Pal, A; Crespo, M; Ferreira, A; Gurel, B; Prout, T; Ameratunga, M; Chénard-Poirier, M; Curcean, A; Bertan, C; Baker, C; Miranda, S; Masrour, N; Chen, W; Pereira, R; Figueiredo, I; Morilla, R; Jenkins, B; Zachariou, A; Riisnaes, R; Parmar, M; Turner, A; Carreira, S; Yap, C; Brown, R; Tunariu, N; Banerji, U; Lopez, J; De Bono, J; Minchom, A; - view fewer (2022) Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors. Journal for ImmunoTherapy of Cancer , 10 (6) , Article e004495. 10.1136/jitc-2022-004495.

Parker, CC; Catton, CN; Clarke, N; Meidahl, P; Parmar, M; Parulekar, W; Sydes, M; (2024) Reply to "Letter to the Editor regarding "Timing of radiotherapy (RT) after radical prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]", by C. C. Parker et al.". Annals of Oncology , 35 (8) pp. 752-753. 10.1016/j.annonc.2024.05.001.

Parker, CC; Clarke, NW; Cook, AD; Petersen, PM; Catton, CN; Cross, WR; Kynaston, H; ... Sydes, MR; + view all Parker, CC; Clarke, NW; Cook, AD; Petersen, PM; Catton, CN; Cross, WR; Kynaston, H; Persad, RA; Saad, F; Logue, J; Payne, H; Amos, C; Bower, L; Raman, R; Sayers, I; Worlding, J; Parulekar, WR; Parmar, MKB; Sydes, MR; - view fewer (2024) Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047). European Urology 10.1016/j.eururo.2024.07.026. (In press).

Parker, CC; Petersen, PM; Cook, AD; Clarke, NW; Catton, C; Cross, WR; Kynaston, H; ... Sydes, MR; + view all Parker, CC; Petersen, PM; Cook, AD; Clarke, NW; Catton, C; Cross, WR; Kynaston, H; Parulekar, WR; Persad, RA; Saad, F; Bower, L; Durkan, GC; Logue, J; Maniatis, C; Noor, D; Payne, H; Anderson, J; Bahl, AK; Bashir, F; Bottomley, DM; Brasso, K; Capaldi, L; Chung, C; Cooke, PW; Donohue, JF; Eddy, B; Heath, CM; Henderson, A; Henry, A; Jaganathan, R; Jakobsen, H; James, ND; Joseph, J; Lees, K; Lester, J; Lindberg, H; Makar, A; Morris, SL; Oommen, N; Ostler, P; Owen, L; Patel, P; Pope, A; Popert, R; Raman, R; Ramani, V; Roder, A; Sayers, I; Simms, M; Srinivasan, V; Sundaram, S; Tarver, KL; Tran, A; Wells, P; Wilson, J; Zarkar, AM; Parmar, MKB; Sydes, MR; - view fewer (2024) Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047). Annals of Oncology , 35 (7) pp. 656-666. 10.1016/j.annonc.2024.03.010.

Parker, Chris C; James, Nicholas D; Brawley, Christopher D; Clarke, Noel W; Ali, Adnan; Amos, Claire L; Attard, Gerhardt; ... Sydes, Matthew R; + view all Parker, Chris C; James, Nicholas D; Brawley, Christopher D; Clarke, Noel W; Ali, Adnan; Amos, Claire L; Attard, Gerhardt; Chowdhury, Simon; Cook, Adrian; Cross, William; Dearnaley, David P; Douis, Hassan; Gilbert, Duncan C; Gilson, Clare; Gillessen, Silke; Hoyle, Alex; Jones, Rob J; Langley, Ruth E; Malik, Zafar I; Mason, Malcolm D; Matheson, David; Millman, Robin; Rauchenberger, Mary; Rush, Hannah; Russell, J Martin; Sweeney, Hannah; Bahl, Amit; Birtle, Alison; Capaldi, Lisa; Din, Omar; Ford, Daniel; Gale, Joanna; Henry, Ann; Hoskin, Peter; Kagzi, Mohammed; Lydon, Anna; O’Sullivan, Joe M; Paisey, Sangeeta A; Parikh, Omi; Pudney, Delia; Ramani, Vijay; Robson, Peter; Srihari, Narayanan Nair; Tanguay, Jacob; Parmar, Mahesh KB; Sydes, Matthew R; - view fewer (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLoS Medicine , 19 (6) , Article e1003998. 10.1371/journal.pmed.1003998.

Parker, CC; Clarke, NW; Cook, AD; Kynaston, HG; Petersen, PM; Catton, C; Cross, W; ... Sydes, MR; + view all Parker, CC; Clarke, NW; Cook, AD; Kynaston, HG; Petersen, PM; Catton, C; Cross, W; Logue, J; Parulekar, W; Payne, H; Persad, R; Pickering, H; Saad, F; Anderson, J; Bahl, A; Bottomley, D; Brasso, K; Chahal, R; Cooke, PW; Eddy, B; Gibbs, S; Goh, C; Gujral, S; Heath, C; Henderson, A; Jaganathan, R; Jakobsen, H; James, ND; Kanaga Sundaram, S; Lees, K; Lester, J; Lindberg, H; Money-Kyrle, J; Morris, S; O'Sullivan, J; Ostler, P; Owen, L; Patel, P; Pope, A; Popert, R; Raman, R; Røder, MA; Sayers, I; Simms, M; Wilson, J; Zarkar, A; Parmar, MKB; Sydes, MR; - view fewer (2020) Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. The Lancet , 396 (10260) pp. 1413-1421. 10.1016/S0140-6736(20)31553-1.

Parker, CC; James, ND; Brawley, CD; Clarke, NW; Hoyle, AP; Ali, A; Ritchie, AWS; ... Systemic Therapy for Advanced or Metastatic Prostate cancer, .; + view all Parker, CC; James, ND; Brawley, CD; Clarke, NW; Hoyle, AP; Ali, A; Ritchie, AWS; Attard, G; Chowdhury, S; Cross, W; Dearnaley, DP; Gillessen, S; Gilson, C; Jones, RJ; Langley, RE; Malik, ZI; Mason, MD; Matheson, D; Millman, R; Russell, JM; Thalmann, GM; Amos, CL; Alonzi, R; Bahl, A; Birtle, A; Din, O; Douis, H; Eswar, C; Gale, J; Gannon, MR; Jonnada, S; Khaksar, S; Lester, JF; O’Sullivan, JM; Parikh, OA; Pedley, ID; Pudney, DM; Sheehan, DJ; Nair Srihari, N; Tran, ATH; Parmar, MKB; Sydes, MR; Systemic Therapy for Advanced or Metastatic Prostate cancer, .; - view fewer (2018) Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet , 392 (10162) pp. 2353-2366. 10.1016/S0140-6736(18)32486-3.

Parker, CC; James, ND; Brawley, CD; Clarke, NW; Parmar, MKB; (2019) Radiotherapy for metastatic prostate cancer – Authors' reply. The Lancet , 394 (10201) p. 830. 10.1016/S0140-6736(19)31829-X.

Parmar, MK; Cafferty, FH; Sydes, MR; Choodari-Oskooei, B; Langley, RE; Brown, L; Phillips, PP; ... Royston, PJ; + view all Parmar, MK; Cafferty, FH; Sydes, MR; Choodari-Oskooei, B; Langley, RE; Brown, L; Phillips, PP; Spears, MR; Rowley, S; Kaplan, R; James, ND; Maughan, T; Paton, N; Royston, PJ; - view fewer (2017) Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols. Clinical Trials , 14 (5) pp. 451-461. 10.1177/1740774517725697.

Parmar, MK; Strang, J; Choo, L; Meade, AM; Bird, SM; (2017) Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths. Addiction , 112 (3) pp. 502-515. 10.1111/add.13668.

Parmar, MKB; Noor, NM; Pett, SL; Esmail, H; Crook, AM; Vale, CL; Sydes, MR; (2020) Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings [version 1; peer review: 2 approved]. F1000Research , 9 , Article 1109. 10.12688/f1000research.26253.1.

Parmar, MKB; Sydes, MR; Morris, TP; (2016) How do you design randomised trials for smaller populations? A framework. BMC Medicine , 14 , Article 183. 10.1186/s12916-016-0722-3.

Petersen, Peter Meidahl; Cook, Adrian D; Sydes, Matthew R; Clarke, Noel; Cross, William; Kynaston, Howard; Logue, John; ... Catton, Charles; + view all Petersen, Peter Meidahl; Cook, Adrian D; Sydes, Matthew R; Clarke, Noel; Cross, William; Kynaston, Howard; Logue, John; Neville, Peter; Payne, Heather; Parmar, Mahesh Kb; Parulekar, Wendy; Persad, Rajendra; Saad, Fred; Stirling, Alan; Parker, Christopher C; Catton, Charles; - view fewer (2023) Salvage radiotherapy after radical prostatectomy: analysis of toxicity by dose-fractionation in the RADICALS-RT trial. International Journal of Radiation: Oncology - Biology - Physics 10.1016/j.ijrobp.2023.04.032. (In press).

Petit, C; Lacas, B; Pignon, J-P; Le, QT; Grégoire, V; Grau, C; Hackshaw, A; ... MACH-NC and MARCH Collaborative Groups; + view all Petit, C; Lacas, B; Pignon, J-P; Le, QT; Grégoire, V; Grau, C; Hackshaw, A; Zackrisson, B; Parmar, MKB; Lee, J-W; Ghi, MG; Sanguineti, G; Temam, S; Cheugoua-Zanetsie, M; O'Sullivan, B; Posner, MR; Vokes, EE; Cruz Hernandez, JJ; Szutkowski, Z; Lartigau, E; Budach, V; Suwiński, R; Poulsen, M; Kumar, S; Ghosh Laskar, S; Mazeron, J-J; Jeremic, B; Simes, J; Zhong, L-P; Overgaard, J; Fortpied, C; Torres-Saavedra, P; Bourhis, J; Aupérin, A; Blanchard, P; MACH-NC and MARCH Collaborative Groups; - view fewer (2021) Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Lancet Oncology , 22 (5) pp. 727-736. 10.1016/S1470-2045(21)00076-0.

Quartagno, M; Carpenter, JR; Walker, AS; Clements, M; Parmar, MKB; (2020) The DURATIONS randomised trial design: Estimation targets, analysis methods and operating characteristics. Clinical Trials 10.1177/1740774520944377. (In press).

Quartagno, M; Walker, AS; Babiker, AG; Turner, RM; Parmar, MKB; Copas, A; White, IR; (2020) Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation. Trials , 21 , Article 145. 10.1186/s13063-020-4070-4.

Quartagno, M; Walker, AS; Carpenter, J; Phillips, P; Parmar, M; (2018) Rethinking non-inferiority: a practical trial design for optimising treatment duration. Clinical Trials , 15 (5) pp. 477-488. 10.1177/1740774518778027.

Ranganathan, P; Chinnaswamy, G; Sengar, M; Gadgil, D; Thiagarajan, S; Bhargava, B; Booth, CM; ... National Cancer Grid of India; + view all Ranganathan, P; Chinnaswamy, G; Sengar, M; Gadgil, D; Thiagarajan, S; Bhargava, B; Booth, CM; Buyse, M; Chopra, S; Frampton, C; Gopal, S; Grant, N; Krailo, M; Langley, R; Mathur, P; Paoletti, X; Parmar, M; Purushotham, A; Pyle, D; Rajaraman, P; Stockler, MR; Sullivan, R; Swaminathan, S; Tannock, I; Trimble, E; Badwe, RA; Pramesh, CS; National Cancer Grid of India; - view fewer (2021) The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research. The Lancet Oncology , 22 (8) e369-e376. 10.1016/S1470-2045(21)00077-2.

Royston, P; Barthel, FMS; Parmar, MKB; Choodari-Oskooei, B; Isham, V; (2011) Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit. Trials , 12 , Article 81. 10.1186/1745-6215-12-81.

Royston, P; Choodari-Oskooei, B; Parmar, MKB; Rogers, JK; (2019) Combined test versus logrank/Cox test in 50 randomised trials. Trials , 20 (1) , Article 172. 10.1186/s13063-019-3251-5.

Royston, P; Parmar, MKB; (2020) A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome. Trials , 21 , Article 315. 10.1186/s13063-020-4153-2.

Royston, P; Parmar, MKB; (2016) Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated. BMC Medical Research Methodology , 16 (1) 10.1186/s12874-016-0110-x.

Royston, P; Parmar, MKB; (2014) An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect. Trials , 15 (1) 10.1186/1745-6215-15-314.

Royston, P; Parmar, MKB; (2013) Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC MEDICAL RESEARCH METHODOLOGY , 13 , Article ARTN 152. 10.1186/1471-2288-13-152.

Rush, HL; Murphy, L; Morgans, AK; Clarke, NW; Cook, AD; Attard, G; Macnair, A; ... Langley, RE; + view all Rush, HL; Murphy, L; Morgans, AK; Clarke, NW; Cook, AD; Attard, G; Macnair, A; Dearnaley, DP; Parker, CC; Russell, JM; Gillessen, S; Matheson, D; Millman, R; Brawley, CD; Pugh, C; Tanguay, JS; Jones, RJ; Wagstaff, J; Rudman, S; O'Sullivan, JM; Gale, J; Birtle, A; Protheroe, A; Gray, E; Perna, C; Tolan, S; McPhail, N; Malik, ZI; Vengalil, S; Fackrell, D; Hoskin, P; Sydes, MR; Chowdhury, S; Gilbert, DC; Parmar, MKB; James, ND; Langley, RE; - view fewer (2021) Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. Journal of Clinical Oncology 10.1200/JCO.21.00728. (In press).

Rydzewska, LHM; Burdett, S; Vale, CL; Clarke, NW; Fizazi, K; Kheoh, T; Mason, MD; ... STOPCaP Abiraterone Collaborators; + view all Rydzewska, LHM; Burdett, S; Vale, CL; Clarke, NW; Fizazi, K; Kheoh, T; Mason, MD; Miladinovic, B; James, ND; Parmar, MKB; Spears, MR; Sweeney, CJ; Sydes, MR; Tran, N; Tierney, JF; STOPCaP Abiraterone Collaborators; - view fewer (2017) Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. European Journal of Cancer , 84 pp. 88-101. 10.1016/j.ejca.2017.07.003.

Rydzewska, LHM; Burdett, S; Vale, CL; Parmar, MKB; Tierney, JF; (2018) Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. European Journal of Cancer , 94 pp. 218-229. 10.1016/j.ejca.2018.02.002.

Sabin, T; Matcham, J; Bray, S; Copas, A; Parmar, MK; (2014) A quantitative process for enhancing end of phase 2 decisions. Statistics in Biopharmaceutical Research , 6 (1) 67 - 77. 10.1080/19466315.2013.852617.

Schiavone, F; Bathia, R; Letchmanan, K; Masters, L; Amos, C; Bara, A; Brown, L; ... Sydes, MR; + view all Schiavone, F; Bathia, R; Letchmanan, K; Masters, L; Amos, C; Bara, A; Brown, L; Gilson, C; Pugh, C; Atako, N; Hudson, F; Parmar, M; Langley, R; Kaplan, R; Parker, C; Attard, G; Clarke, NW; Gillessen, S; James, ND; Maughan, T; Sydes, MR; - view fewer (2019) This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols. Trials , 20 , Article 264. 10.1186/s13063-019-3216-8.

Seligmann, JF; Fisher, DJ; Brown, LC; Adams, RA; Graham, J; Quirke, P; Richman, SD; ... FOCUS4 Trial Investigators, .; + view all Seligmann, JF; Fisher, DJ; Brown, LC; Adams, RA; Graham, J; Quirke, P; Richman, SD; Butler, R; Domingo, E; Blake, A; Yates, E; Braun, M; Collinson, F; Jones, R; Brown, E; de Winton, E; Humphrey, TC; Parmar, M; Kaplan, R; Wilson, RH; Seymour, M; Maughan, TS; FOCUS4 Trial Investigators, .; - view fewer (2021) Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. Journal of Clinical Oncology 10.1200/JCO.21.01435. (In press).

South, A; Bailey, J; Parmar, MKB; Vale, CL; (2019) Effectiveness and acceptability of methods of communicating the results of clinical research to lay and professional audiences: protocol for a systematic review. Systematic Reviews , 8 , Article 150. 10.1186/s13643-019-1065-x.

South, A; Parulekar, WR; Sydes, MR; Chen, BE; Parmar, MK; Clarke, N; Warde, P; South, A; Parulekar, WR; Sydes, MR; Chen, BE; Parmar, MK; Clarke, N; Warde, P; Mason, M; - view fewer (2016) Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer. European Urology Focus , 2 (3) pp. 276-283. 10.1016/j.euf.2015.11.004.

STARSurg Collaborative; the EuroSurg Collaborative; (2024) Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study. Anaesthesia , 79 (7) pp. 715-724. 10.1111/anae.16220.

Stephens, RJ; Langley, RE; Nankivell, M; Parmar, MKB; Mulvenna, P; Vail, A; (2014) Interim results in clinical trials: Do we need to keep all interim randomised clinical trial results confidential? Lung Cancer , 85 (2) 116 - 118. 10.1016/j.lungcan.2014.05.012.

Stott, W; Campbell, S; Franchini, A; Blyuss, O; Zaikin, A; Ryan, A; Jones, C; ... Menon, U; + view all Stott, W; Campbell, S; Franchini, A; Blyuss, O; Zaikin, A; Ryan, A; Jones, C; Gentry-Maharaj, A; Fletcher, G; Kalsi, J; Skates, S; Parmar, M; Amso, N; Jacobs, I; Menon, U; - view fewer (2017) Self-reported transvaginal ultrasound visualization of normal ovaries in postmenopausal women is not reliable: results of expert review of archived images in UKCTOCS. Ultrasound Obstet Gynecol 10.1002/uog.18836. (In press).

Stott, W; Gentry-Maharaj, A; Ryan, A; Amso, N; Seif, M; Jones, C; Jacobs, I; ... Burnell, M; + view all Stott, W; Gentry-Maharaj, A; Ryan, A; Amso, N; Seif, M; Jones, C; Jacobs, I; Parmar, M; Menon, U; Campbell, S; Burnell, M; - view fewer (2018) Audit of transvaginal sonography of normal postmenopausal ovaries by sonographers from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). F1000 Research , 7 , Article 1241. 10.12688/f1000research.15663.1.

Sydes, MR; (2018) Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. Annals Of Oncology , 29 (5) pp. 1235-1248. 10.1093/annonc/mdy072.

Sydes, MR; (2015) Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019). European Urology , 67 (6) pp. 1028-1038. 10.1016/j.eururo.2014.09.032.

Sydes, MR; Johnson, AL; Meredith, SK; Rauchenberger, M; South, A; Parmar, MK; (2015) Sharing data from clinical trials: the rationale for a controlled access approach. Trials , 16 (1) , Article 104. 10.1186/s13063-015-0604-6.

Sydes, MR; Parmar, MK; Mason, MD; Clarke, NW; Amos, C; Anderson, J; de Bono, J; ... James, ND; + view all Sydes, MR; Parmar, MK; Mason, MD; Clarke, NW; Amos, C; Anderson, J; de Bono, J; Dearnaley, DP; Dwyer, J; Green, C; Jovic, G; Ritchie, AW; Russell, JM; Sanders, K; Thalmann, G; James, ND; - view fewer (2012) Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial. Trials , 13 , Article 168. 10.1186/1745-6215-13-168.

Sydes, MR; Parmar, MKB; James, ND; Clarke, NW; Dearnaley, DP; Mason, MD; Morgan, RC; ... Royston, P; + view all Sydes, MR; Parmar, MKB; James, ND; Clarke, NW; Dearnaley, DP; Mason, MD; Morgan, RC; Sanders, K; Royston, P; - view fewer (2009) Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial. Trials , 10 , Article 39. 10.1186/1745-6215-10-39.

Taylor, JA; Burnell, M; Ryan, A; Karpinskyj, C; Kalsi, JK; Taylor, H; Apostolidou, S; ... Gentry-Maharaj, A; + view all Taylor, JA; Burnell, M; Ryan, A; Karpinskyj, C; Kalsi, JK; Taylor, H; Apostolidou, S; Sharma, A; Manchanda, R; Woolas, R; Campbell, S; Parmar, M; Singh, N; Jacobs, IJ; Menon, U; Gentry-Maharaj, A; - view fewer (2022) Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS. BJOG: An International Journal of Obstetrics and Gynaecology , 129 (1) pp. 110-118. 10.1111/1471-0528.16943.

Tierney, J; Vale, CL; Burdett, S; Fisher, D; Rydzewska, L; Parmar, MKB; (2017) Timely and reliable evaluation of the effects of interventions: a framework for adaptive meta-analysis (FAME). Trials , 18 (Suppl.1) , Article P351. 10.1186/s13063-017-1902-y.

Tierney, JF; Fisher, DJ; Burdett, S; Stewart, LA; Parmar, MKB; (2020) Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study. PLoS Med , 17 (1) , Article e1003019. 10.1371/journal.pmed.1003019.

Tierney, JF; Fisher, DJ; Vale, CL; Burdett, S; Rydzewska, LH; Rogozińska, E; Godolphin, PJ; ... Parmar, MKB; + view all Tierney, JF; Fisher, DJ; Vale, CL; Burdett, S; Rydzewska, LH; Rogozińska, E; Godolphin, PJ; White, IR; Parmar, MKB; - view fewer (2021) A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials. PLoS Medicine , 18 (5) , Article e1003629. 10.1371/journal.pmed.1003629. (In press).

Tierney, JF; Pignon, JP; Gueffyier, F; Clarke, M; Askie, L; Vale, CL; Burdett, S; Tierney, JF; Pignon, JP; Gueffyier, F; Clarke, M; Askie, L; Vale, CL; Burdett, S; Cochrane IPDs Methods Group; - view fewer (2015) How individual participant data meta-analyses have influenced trial design, conduct, and analysis. Journal of Clinical Epidemiology , 68 (11) pp. 1325-1335. 10.1016/j.jclinepi.2015.05.024.

Vale, CL; Burdett, S; Fisher, DJ; Navani, N; Parmar, MK; Copas, AJ; Tierney, JF; (2014) Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials. Clinical Lung Cancer , 16 (3) 173- 182.e4. 10.1016/j.cllc.2014.11.007.

Vale, CL; Burdett, S; Rydzewska, LH; Albiges, L; Clarke, NW; Fisher, D; Fizazi, K; ... Tierney, JF; + view all Vale, CL; Burdett, S; Rydzewska, LH; Albiges, L; Clarke, NW; Fisher, D; Fizazi, K; Gravis, G; James, ND; Mason, MD; Parmar, MK; Sweeney, CJ; Sydes, MR; Tombal, B; Tierney, JF; - view fewer (2016) Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. The Lancet Oncology , 17 (2) pp. 243-256. 10.1016/S1470-2045(15)00489-1.

Vale, CL; Fisher, D; Kneebone, A; Parker, C; Pearse, M; Richaud, P; Sargos, P; ... Tierney, JF; + view all Vale, CL; Fisher, D; Kneebone, A; Parker, C; Pearse, M; Richaud, P; Sargos, P; Sydes, MR; Brawley, C; Brihoum, M; Brown, C; Chabaud, S; Cook, A; Forcat, S; Fraser-Browne, C; Latorzeff, I; Parmar, MKB; Tierney, JF; - view fewer (2020) Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. The Lancet , 396 pp. 1422-1431. 10.1016/S0140-6736(20)31952-8.

Vale, CL; Fisher, D; White, I; Carpenter, J; Burdett, S; Clarke, N; Fizazi, K; ... Tierney, J; + view all Vale, CL; Fisher, D; White, I; Carpenter, J; Burdett, S; Clarke, N; Fizazi, K; Gravis, G; James, N; Mason, M; Parmar, M; Rydzewska, L; Sweeney, C; Spears, M; Sydes, M; Tierney, J; - view fewer (2018) What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis. Annals of Oncology , 29 (5) pp. 1249-1257. 10.1093/annonc/mdy071.

Webb, AB; Berg, CD; Castle, PE; Crosby, D; Etzioni, R; Kessler, LG; Menon, U; ... Sasieni, PD; + view all Webb, AB; Berg, CD; Castle, PE; Crosby, D; Etzioni, R; Kessler, LG; Menon, U; Parmar, M; Steele, RJC; Sasieni, PD; - view fewer (2024) Considerations for using potential surrogate endpoints in cancer screening trials. The Lancet Oncology , 25 (5) e183-e192. 10.1016/S1470-2045(24)00015-9.

Wong, Charis; Dakin, Rachel S; Williamson, Jill; Newton, Judith; Steven, Michelle; Colville, Shuna; Stavrou, Maria; ... Chandran, Siddharthan; + view all Wong, Charis; Dakin, Rachel S; Williamson, Jill; Newton, Judith; Steven, Michelle; Colville, Shuna; Stavrou, Maria; Gregory, Jenna M; Elliott, Elizabeth; Mehta, Arpan R; Chataway, Jeremy; Swingler, Robert J; Parker, Richard Anthony; Weir, Christopher J; Stallard, Nigel; Parmar, Mahesh KB; Macleod, Malcolm R; Pal, Suvankar; Chandran, Siddharthan; - view fewer (2022) Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease. BMJ Open , 12 (7) , Article e064173. 10.1136/bmjopen-2022-064173.

Woods, BS; Sideris, E; Sydes, MR; Gannon, MR; Parmar, MKB; Alzouebi, M; Attard, G; ... Sculpher, MJ; + view all Woods, BS; Sideris, E; Sydes, MR; Gannon, MR; Parmar, MKB; Alzouebi, M; Attard, G; Birtle, AJ; Brock, S; Cathomas, R; Chakraborti, PR; Cook, A; Cross, WR; Dearnaley, DP; Gale, J; Gibbs, S; McLaren, DB; Millman, R; O'Sullivan, JM; Parikh, O; Parker, CC; Peedell, C; Srihari, NN; Srinivasan, R; Staffurth, JN; Sundar, S; Thalmann, GN; Tolan, S; Tran, ATH; Tsang, D; Wagstaff, J; James, ND; Sculpher, MJ; - view fewer (2018) Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. European Urology Oncology , 1 (6) pp. 449-458. 10.1016/j.euo.2018.06.004.

Zakeri, K; Rotolo, F; Lacas, B; Vitzthum, LK; Le, Q-T; Gregoire, V; Overgaard, J; ... MARCH/MACH-NC Collaborative Group and the Head and Neck Cancer I; + view all Zakeri, K; Rotolo, F; Lacas, B; Vitzthum, LK; Le, Q-T; Gregoire, V; Overgaard, J; Hackshaw, A; Zackrisson, B; Parmar, MKB; Burtness, BA; Ghi, MG; Sanguineti, G; O'Sullivan, B; Fortpied, C; Bourhis, J; Shen, H; Harris, J; Michiels, S; Pignon, J-P; Mell, LK; MARCH/MACH-NC Collaborative Group and the Head and Neck Cancer I; - view fewer (2020) Predictive classifier for intensive treatment of head and neck cancer. Cancer , 126 (24) pp. 5263-5273. 10.1002/cncr.33212.

Zeissler, M-L; Li, V; Parmar, MKB; Carroll, CB; (2020) Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson's Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer. Journal of Parkinson's Disease , 10 (2) pp. 413-428. 10.3233/JPD-191856.

Proceedings paper

James, N; Woods, B; Sideris, E; Spears, MR; Dearnaley, DP; Mason, M; Clarke, N; ... Sculpher, M; + view all James, N; Woods, B; Sideris, E; Spears, MR; Dearnaley, DP; Mason, M; Clarke, N; Parmar, MKB; Sydes, MR; Sculpher, M; - view fewer (2018) Addition of docetaxel to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Long-term survival, quality-adjusted survival, and cost-effectiveness analysis. In: Figlin, Robert and Spielberg, Steven, (eds.) Proceedings of the 2018 Genitourinary Cancers Symposium. American Society of Clinical Oncology (ASCO): San Francisco, CA, USA.

Working / discussion paper

Burnell, M; Gentry-Maharaj, A; Skates, S; Ryan, A; Karpinskyj, C; Kalsi, J; Apostolidou, S; ... Menon, U; + view all Burnell, M; Gentry-Maharaj, A; Skates, S; Ryan, A; Karpinskyj, C; Kalsi, J; Apostolidou, S; Singh, N; Dawnay, A; Woolas, R; Fallowfield, L; Campbell, S; McGuire, A; Jacobs, I; Parmar, M; Menon, U; - view fewer (2020) UKCTOCS Update: Applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis. MedRxiv: Cold Spring Harbor, NY, USA.

Conference item

Cook, A; Embleton, A; Jayson, G; Kaplan, R; Kristensen, G; Parmar, MK; Pfisterer, J; ... Perren, T; + view all Cook, A; Embleton, A; Jayson, G; Kaplan, R; Kristensen, G; Parmar, MK; Pfisterer, J; Pujade-Lauraine, E; Oza, AM; Perren, T; - view fewer (2017) ICON7: Ovarian cancer, platinum second-line chemotherapy and overall survival. Presented at: 42nd ESMO Congress (ESMO 2017), Madrid, Spain.

Gentry-Maharaj, A; Skates, S; Sharma, A; Burnell, M; Ryan, A; Grant, S; Ford, J; ... Menon, U; + view all Gentry-Maharaj, A; Skates, S; Sharma, A; Burnell, M; Ryan, A; Grant, S; Ford, J; Dawnay, A; Parmar, M; Jacobs, I; Menon, U; - view fewer (2006) Risk of Ovarian Cancer (Roc) Algorithm Increases Specificity of Ca125 in Ovarian Cancer Screening. Presented at: International Gynecologic Cancer Society (IGCS), Santa Monica, CA, USA.

Langley, RE; Duong, T; Clarke, NW; Kynaston, K; Rosen, SD; Nankivell, M; Dearnaley, D; ... Abel, P; + view all Langley, RE; Duong, T; Clarke, NW; Kynaston, K; Rosen, SD; Nankivell, M; Dearnaley, D; Kockelbergh, R; Godsland, IF; Sundaram, SK; Dixit, S; Laniado, M; Pope, A; Tyson, C; Goldstein, C; Parmar, MK; Gilbert, D; Abel, P; - view fewer (2018) PATCH - Prostate adenocarcinoma: transcutaneous hormones. A randomised comparison evaluating cardiovascular morbidity and mortality of transdermal oestradiol versus luteinising hormone-releasing hormone agonists in advanced prostate cancer. Presented at: The British Associations of Urological Surgeons (BAUS) Annual Scientific Meeting, Liverpool, UK.

This list was generated on Sun Sep 14 04:40:56 2025 BST.